post-operative pain after rhinoplasty. Acute pain, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group1: One hour before surgery, patients receive an oral capsule containing 100 mg Sumatriptan with 100 ml of drinking water. Intervention 2: Intervention group2: One hou
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adult individuals volunteering for rhinoplasty with ASA I status.
Exclusion criteria
Exclusion criteria: Patients with a history of substance abuse, drug abuse or alcohol abuse Patients with kidney or liver failure Patients with diabetes or history of diabetes Patients who are allergic to any of the drugs used in this trial Patients who use antidiabetic medications, antidepressants, anticonvulsants or antihypertensive medications Patients who use painkillers daily or 24 hours before the surgery Patients who are unable to cooperate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of postoperative pain. Timepoint: At 2,4,6,12,24 hours after the end of operation. Method of measurement: Using the Visual Analogue Scale(VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and Vomiting. Timepoint: Within 24 hours after surgery. Method of measurement: Yes/No.;Drowsiness. Timepoint: Within 24 hours after surgery. Method of measurement: Yes/No. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamed Nazari
Kermanshah University of Medical Sciences
Outcome results
None listed